Aurora Cannabis Inc. ACB
Medicinal Chemicals and Botanical Products · data as of November 13, 2026
Aurora Cannabis Inc. (ACB) is a healthcare company listed in the US with a market value of about $325M. In the twelve months to September 30, 2026 it had revenue of $225M and net income of -$62M, a net margin of -27.4%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 5% a year, a 5-year average ROIC of -15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 81% below the current price.
About Aurora Cannabis
Aurora Cannabis is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $42M in 2018 to $225M in 2026, growth of about 23.4% a year. It was profitable in 2 of the last 8 years in our data. Its share count fell by 14% over three years (buybacks).
Score: 0.6 / 5
Checks passed
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Share count down over 3 years (buybacks)
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $225M | $225M | $239M | $199M | $171M | $198M | $196M | $188M | $42M |
| Net income | -$62M | -$95M | $1M | -$51M | -$1.3B | -$559M | -$2.4B | -$224M | $54M |
| Free cash flow | -$18M | -$25M | -$2M | -$63M | -$110M | -$213M | — | -$463M | -$165M |
| EPS (diluted) | $-1.02 | $-1.68 | $0.02 | $-0.78 | $-20.21 | $-8.50 | $-36.49 | $-3.41 | $0.83 |
| Net margin | -27.4% | -42.4% | 0.5% | -25.7% | -776.0% | -282.2% | -1221.7% | -119.5% | 130.3% |
| ROIC | — | — | 0.6% | -7.2% | -34.9% | -13.8% | -19.3% | -6.4% | -5.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Aurora Cannabis stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 81% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Aurora Cannabis pay a dividend?
Not currently.
Is Aurora Cannabis a good stock to buy?
We do not give buy or sell advice. Aurora Cannabis scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.